CASSIDY JUDA: Open Payments
NPI 1245410042 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 33 payments from 7 companies in 2025. Trend: 2023 $662 · 2024 $520 · 2025 $521
Food & beverage: $511Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $342 |
| LEO Pharma Inc. | 3 | $78 |
| Galderma Laboratories, L.P. | 1 | $25 |
| GENZYME CORPORATION | 1 | $22 |
| Amgen Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| MERZ NORTH AMERICA, INC. | 1 | $16 |
Products named: SKYRIZI, ADBRY, RINVOQ, NEMLUVIO, DUPIXENT, OTEZLA, TALTZ.
Industry payments across MT — which companies pay providers there.
